Intra Cellular Therapies | 营业费用

Operating Expenses 更改 日
Acadia Pharmaceuticals USD 196.1M 73.38M 2023-12
Cytokinetics USD 129.09M 6.45M 2023-12
Gilead Sciences USD 5.5B 1.08B 2023-12
Halozyme Therapeutics USD 129M 1.25M 2023-12
Intra Cellular Therapies USD 166.2M 10.31M 2023-12
RedHill Biopharma USD 6.2M 31.68M 2023-06
Supernus Pharmaceuticals USD 165.31M 19.57M 2023-12



Intra Cellular Therapies 营业费用 - 当前值，历史数据，预测，统计，图表和经济日历 - May 2024.